Stay updated on ARCHES-2 Study: ARO-ANG3 Clinical Trial
Sign up to get notified when there's something new on the ARCHES-2 Study: ARO-ANG3 Clinical Trial page.

Latest updates to the ARCHES-2 Study: ARO-ANG3 Clinical Trial page
- Check5 days agoChange DetectedStudy record content and structure appear unchanged between versions; no new or removed sections or fields were detected.SummaryDifference0.3%

- Check12 days agoNo Change Detected
- Check34 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

- Check41 days agoChange DetectedUpdate to revision v3.1.0 with removal of several drug-safety related topics and MeSH terms, indicating a narrowing of scope rather than a substantive new content addition.SummaryDifference0.9%

- Check55 days agoChange DetectedRevision changed from v3.0.1 to v3.0.2, and the 'Back to Top' control was removed. No visible changes to core content such as pricing or availability.SummaryDifference0.2%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check70 days agoChange DetectedThe web page has added significant information regarding the facility name, location, and relevant publications, while removing several location-related terms and specific medical conditions.SummaryDifference7%

Stay in the know with updates to ARCHES-2 Study: ARO-ANG3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARCHES-2 Study: ARO-ANG3 Clinical Trial page.